These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 847450

  • 21. What to do when Sinemet fails: Part one.
    Klawans HL.
    Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
    [No Abstract] [Full Text] [Related]

  • 22. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa.
    Aarli JA, Gilhus NE.
    Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767
    [Abstract] [Full Text] [Related]

  • 23. Trial of Sinemet CR4 in patients with Parkinson's disease.
    Anderson TJ, Ewer TC, Gilchrist NL, Donaldson IM.
    N Z Med J; 1992 Mar 11; 105(929):81-2. PubMed ID: 1545941
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sinemet.
    Drug Ther Bull; 1974 Oct 11; 12(21):83-4. PubMed ID: 4617660
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep 11; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 27. Pharmacotherapy: problems and practices.
    Muenter MD.
    Clin Neuropharmacol; 1986 Sep 11; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 32. [5 years of experience in the treatment of parkinsonism with L-dopa and its combination with Ro4-4602].
    Romero S, Chouza C, Gomensoro JB.
    Neurol Neurocir Psiquiatr; 1976 Mar 23; 17(4):239-54. PubMed ID: 1018727
    [Abstract] [Full Text] [Related]

  • 33. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M, Miwa H, Kondo T.
    No To Shinkei; 2002 Feb 23; 54(2):127-32. PubMed ID: 11889758
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE, Tolosa ES, Loewenson RB, Lee MC, Resch JA, Baker AB.
    Geriatrics; 1975 Dec 23; 30(12):39-44. PubMed ID: 1104406
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial.
    Pakkenberg H, Birket-Smith E, Dupont E, Hansen E, Mikkelsen B, Presthus J, Rautakorpi I, Riman E, Rinne UK.
    Acta Neurol Scand; 1976 May 23; 53(5):376-85. PubMed ID: 1266576
    [Abstract] [Full Text] [Related]

  • 40. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P, Cote L, Fahn S.
    Adv Neurol; 1993 May 23; 60():703-6. PubMed ID: 8420214
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.